Abstract
ObjectivesTo describe (i) the trend in oral anticoagulant (OAC) use following the introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke prevention in atrial fibrillation (AF) patients and...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have